Oragenics appoints Janet Huffman as CFO effective March 7, 2023

ORAGENICS INC

Janet Huffman named CFO, Secretary and Treasurer; base salary $250,000, target bonus 35%.
Granted 7,000 stock options at $4.00 exercise price under 2021 Equity Incentive Plan.
Options vest in five equal tranches over two years; severance includes 6 months salary if terminated without cause.
Huffman previously CFO of TRxADE HEALTH and Arboreta Healthcare; brings public company finance and M&A experience.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Janet Huffman

Chief Financial Officer

OGEN · ORAGENICS INC

Effective: 2023-03-07
Filed: March 8, 2023, 6:59 PM ET

announced that the Board of Directors approved the appointment of Janet Huffman, as the Company’s new Chief Financial Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Janet Huffman was appointed as Chief Financial Officer at ORAGENICS INC.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

announced that the Board of Directors approved the appointment of Janet Huffman, as the Company’s new Chief Financial Officer

View on SEC.gov

ORAGENICS INC filing history →

Source: SEC EDGAR

accession 0001493152-23-006979

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.